145 related articles for article (PubMed ID: 25269574)
1. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
[TBL] [Abstract][Full Text] [Related]
3. [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer].
Wang L; Cai Y; Shi Y; Yao M; Pan LH; Gu JJ; Yang XL; Wu W; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):493-499. PubMed ID: 27784426
[No Abstract] [Full Text] [Related]
4. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
[TBL] [Abstract][Full Text] [Related]
5. B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells.
Yao X; Li X; Zhang D; Xie Y; Sun B; Li H; Sun L; Zhang X
Tumour Biol; 2017 Mar; 39(3):1010428317695965. PubMed ID: 28351336
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.
Zhai BJ; Shao ZY; Zhao CL; Hu K; Wu F
World J Gastroenterol; 2006 Nov; 12(41):6614-9. PubMed ID: 17075973
[TBL] [Abstract][Full Text] [Related]
7. [Study on sensitivity to chemotherapy by combination therapy with tumor necrosis factor-alpha and bromocriptine in the multidrug resistant subcell line of HepG2].
Ding L; Chen XP; Zhang ZW; Jing K; Cao B; Zhu P; Li J; Zhang DY
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1644-7. PubMed ID: 17359700
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/Adm) and biological characteristics evaluation].
Zhai BJ; Wu F; Shao ZY; Hu K; Wang ZB
Ai Zheng; 2004 Apr; 23(4):391-5. PubMed ID: 15087025
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells.
Yan F; Wang XM; Pan C; Ma QM
World J Gastroenterol; 2009 Mar; 15(12):1443-51. PubMed ID: 19322916
[TBL] [Abstract][Full Text] [Related]
10. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
[TBL] [Abstract][Full Text] [Related]
11. [Effect of inhibiting survivin expression with antisense oligodeoxynucleotides on sensitivity of hepatocellular carcinoma cell lines HepG2 and HepG2/ADM to adriamycin].
Dai DJ; Lu CD; Guo JM; Zhang J
Ai Zheng; 2005 Aug; 24(8):951-7. PubMed ID: 16086872
[TBL] [Abstract][Full Text] [Related]
12. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
Qian JQ; Sun P; Pan ZY; Fang ZZ
Int J Clin Exp Pathol; 2015; 8(9):11934-44. PubMed ID: 26617951
[TBL] [Abstract][Full Text] [Related]
13. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
Lu L; Zhang D; Xu Y; Bai G; Lv Y; Liang J
Biomed Pharmacother; 2018 Aug; 104():613-621. PubMed ID: 29803174
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
Zhao M; Yu S; Zhang M
Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
[TBL] [Abstract][Full Text] [Related]
15. miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5‑fluorouracil by targeting EIF4E.
Yang X; Zang J; Pan X; Yin J; Xiang Q; Yu J; Gan R; Lei X
Oncol Rep; 2017 Jan; 37(1):563-570. PubMed ID: 27840964
[TBL] [Abstract][Full Text] [Related]
16. EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
Yan F; Bai LP; Gao H; Zhu CM; Lin L; Kang XP
Asian Pac J Cancer Prev; 2014; 15(6):2619-23. PubMed ID: 24761873
[TBL] [Abstract][Full Text] [Related]
17. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
[TBL] [Abstract][Full Text] [Related]
19. [Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine].
Ding L; Chen XP; Zhang ZW; Zhang WG; Cao B; Wang ZH; Li CL
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):353-7. PubMed ID: 16732910
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells.
Liu CL; Lim YP; Hu ML
Mar Drugs; 2013 Jan; 11(1):50-66. PubMed ID: 23299493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
